You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Details for Patent: 8,883,838


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,883,838 protect, and when does it expire?

Patent 8,883,838 protects RHOFADE and is included in one NDA.

This patent has seventeen patent family members in eleven countries.

Summary for Patent: 8,883,838
Title:Pharmaceutical cream compositions and methods of use
Abstract: The present invention provides pharmaceutical cream compositions comprising oxymetazoline and methods for treating rosacea and other skin disorders as described herein using the above cream compositions.
Inventor(s): Shanler; Stuart D. (Pomona, NY), Powala; Christopher (Radnor, PA), Rios; Luis (Pembroke Pines, FL)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:13/309,403
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,883,838
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 8,883,838

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma RHOFADE oxymetazoline hydrochloride CREAM;TOPICAL 208552-001 Jan 18, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,883,838

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011336449 ⤷  Sign Up
Australia 2016238909 ⤷  Sign Up
Australia 2018229508 ⤷  Sign Up
Canada 2819633 ⤷  Sign Up
Denmark 2645993 ⤷  Sign Up
European Patent Office 2645993 ⤷  Sign Up
European Patent Office 3181121 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.